Melanopsin plays a key role in the inner workings of the eye

NewsGuard 100/100 Score

A Brown University team has found that a protein called melanopsin plays a key role in the inner workings of mysterious, spidery cells in the eye called intrinsically photosensitive retinal ganglion cells, or ipRGCs.A Brown University team has found that a protein called melanopsin plays a key role in the inner workings of mysterious, spidery cells in the eye called intrinsically photosensitive retinal ganglion cells, or ipRGCs.

Melanopsin, they found, absorbs light and triggers a biochemical cascade that allows the cells to signal the brain about brightness. Through these signals, ipRGCs synchronize the body’s daily rhythms to the rising and setting of the sun. This circadian rhythm controls alertness, sleep, hormone production, body temperature and organ function.

Brown researchers, led by neuroscientist David Berson, announced the discovery of ipRGCs in 2002. Their work was astonishing: Rods and cones aren’t the only light-sensitive eye cells.

Like rods and cones, ipRGCs turn light energy into electrical signals. But while rods and cones aid sight by detecting objects, colors and movement, ipRGCs gauge overall light intensity. Numbering only about 1,000 to 2,000 out of millions of eyes cells, ipRGCs are different in another way: They have a direct link to brain, sending a message to the tiny region that controls the body clock about how light or dark the environment is. The cells are also responsible for narrowing the pupil of the eye.

“It’s a general brightness detection system in the eye,” said Berson, the Sidney A. Fox and Dorothea Doctors Fox Professor of Ophthalmology and Visual Sciences. “What we’ve done now is provide more details about how this system works.”

The research, published in the current issue of Nature, provides the first evidence that melanopsin is a functional sensory photopigment. In other words, this protein absorbs light and sets off a chain of chemical reactions in a cell that triggers an electrical response. The study also showed that melanopsin plays this role in ganglion-cell photoreceptors, helping them send a powerful signal to the brain that it is day or night.

The team made the discovery by inserting melanopsin into cells taken from the kidneys and grown in culture. These cells, which are not normally sensitive to light, were transformed into photoreceptors when flooded with melanopsin. In fact, the kidney cells responded to light almost exactly the way ipRGCs do, confirming that melanopsin is the photopigment for ganglion-cell photoreceptors.

“This resolves a key question about the function of these cells,” Berson said. “And so little is known about them, anything we learn is important.”

Berson and his team made another intriguing finding: The biochemical cascade sparked by melanopsin is closer to that of eye cells in invertebrates like fruit flies and squid than in spined animals such as mice, monkeys or humans.

“The results may well tell us that this is an extremely ancient system in terms of evolution,” Berson said. “We may have a bit of the invertebrate in our eyes.”

The research team from Brown included lead author and post-doctoral research associate Xudong Qiu and post-doctoral research associate Kwoon Wong, both in the Department of Neuroscience, as well as graduate students Stephanie Carlson and Vanitha Krishna in the Neuroscience Graduate Program. Tida Kumbalasiri and Ignacio Provencio from the Uniformed Services University of the Health Sciences also contributed to the research.

The National Institutes of Health funded the work.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Exonate first-in-class eye drop Phase Ib/IIa trial data demonstrate safety and biological activity in treatment of diabetic retinopathy and diabetic macular oedema